Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02361944 · ClinicalTrials.gov registry record · Phase 2
Risk of Oxygen During Cardiac Surgery Trial
A Phase 2 study, sponsored by Vanderbilt University.
- Completed
- Registry status
- Phase 2
- Development phase
- 213
- Enrollment target
NCT02361944 is a Phase 2 study that has completed, run by Vanderbilt University. The registered enrollment target is 213 participants.
The verdict
NCT02361944, a Phase 2 study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 213 participants
- Enrollment target
Study Summary
The investigators will recruit and randomize 200 elective cardiac surgery patients to receive physiologic oxygenation (normoxia) or hyper-oxygenation (hyperoxia) during surgery to test the hypothesis that intraoperative physiologic oxygenation decreases the generation of reactive oxygen species, oxidative damage, and postoperative organ injury compared to hyper-oxygenation.
Interventions
- DRUG Oxygen - normoxia
- DRUG Oxygen - hyperoxia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 213 participants |
| Start Date | 2016-04-05 |
| Est. Completion | 2021-01-08 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02361944
The ClinicalTrials.gov registry entry for NCT02361944 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 213 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Oxygen - normoxia is the first listed.
NCT02361944 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02361944 about?
NCT02361944 is a clinical study titled "Risk of Oxygen During Cardiac Surgery Trial". The investigators will recruit and randomize 200 elective cardiac surgery patients to receive physiologic oxygenation (normoxia) or hyper-oxygenation (hyperoxia) during surgery to test the hypothesis that intraoperative physiologic oxygenation decreases the generation of reactive oxygen species, oxi...
What is the current status of trial NCT02361944?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 213 participants. The study started on 2016-04-05. Estimated completion is 2021-01-08.
What interventions are being tested in trial NCT02361944?
The interventions under investigation include: Oxygen - normoxia (DRUG), Oxygen - hyperoxia (DRUG).
Who is sponsoring clinical trial NCT02361944?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.